IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS was reported 92 times

IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPIDURAL CATHETER PLACEMENT 2 0.1538
1 SUBDURAL ABSCESS 3 0.0652
2 MICROBIOLOGY TEST ABNORMAL 1 0.0169
3 EXTUBATION 1 0.0123
4 HAEMOFILTRATION 1 0.0053
5 EXTRADURAL ABSCESS 3 0.0038
6 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
7 KLEBSIELLA BACTERAEMIA 3 0.0032
8 STENOTROPHOMONAS INFECTION 3 0.0022
9 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
10 INFECTIVE ANEURYSM 1 0.0020
11 MORNING SICKNESS 1 0.0018
12 GRAFT COMPLICATION 1 0.0017
13 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0016
14 INTESTINAL ANASTOMOSIS 1 0.0016
15 RUPTURED CEREBRAL ANEURYSM 1 0.0015
16 ENTEROCOCCUS TEST POSITIVE 1 0.0015
17 ABSCESS DRAINAGE 1 0.0012
18 SKIN GRAFT 1 0.0011
19 PURULENCE 2 0.0010
20 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
21 POSTICTAL STATE 1 0.0010
22 BLADDER DILATATION 1 0.0009
23 PATHOGEN RESISTANCE 8 0.0009
24 PAROTITIS 1 0.0009
25 PROCALCITONIN INCREASED 1 0.0009
26 BILE DUCT CANCER 1 0.0008
27 MULTIMORBIDITY 1 0.0008
28 CULTURE URINE POSITIVE 1 0.0007
29 TRACHEOSTOMY 1 0.0007
30 MYOCLONIC EPILEPSY 1 0.0007
31 PNEUMONIA PSEUDOMONAL 1 0.0007
32 VASOPLEGIA SYNDROME 1 0.0006
33 OXYGEN THERAPY 1 0.0006
34 SEIZURE LIKE PHENOMENA 1 0.0006
35 PARADOXICAL DRUG REACTION 2 0.0005
36 OTOTOXICITY 1 0.0005
37 HYPOREFLEXIA 1 0.0005
38 NOSOCOMIAL INFECTION 1 0.0005
39 TRANSPLANT FAILURE 1 0.0004
40 SYSTEMIC CANDIDA 1 0.0004
41 LARYNGOSPASM 1 0.0004
42 CENTRAL VENOUS CATHETERISATION 1 0.0003
43 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
44 CATHETER SITE INFECTION 1 0.0003
45 PURULENT DISCHARGE 1 0.0002
46 INFLAMMATORY MARKER INCREASED 1 0.0002
47 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
48 PRODUCT LABEL CONFUSION 1 0.0002
49 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
50 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
51 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
52 BRONCHIECTASIS 1 0.0001
53 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
54 INTENTIONAL UNDERDOSE 1 0.0001
55 EPILEPSY 4 0.0001
56 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
57 MYASTHENIA GRAVIS 1 0.0001
58 CARDIO-RESPIRATORY ARREST 5 0.0001
59 LUNG INFILTRATION 1 0.0001
60 EAR DISCOMFORT 1 0.0001
61 ASPIRATION 1 0.0001
62 THERAPY NON-RESPONDER 4 0.0001
63 PANCREATITIS ACUTE 2 0.0001
64 PRODUCT AVAILABILITY ISSUE 2 0.0001
65 BACTERAEMIA 1 0.0001
66 CHOLECYSTITIS 1 0.0001
67 ENCEPHALOPATHY 2 0.0001
68 DRUG RESISTANCE 2 0.0001
69 NODULE 1 0.0001
70 SINUS TACHYCARDIA 1 0.0001
71 ABSCESS 1 0.0001
72 COAGULOPATHY 1 0.0001
73 DRUG ERUPTION 1 0.0001
74 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
75 CHOLESTASIS 1 0.0001
76 RENAL IMPAIRMENT 4 0.0000
77 SEPTIC SHOCK 2 0.0000
78 RESPIRATORY FAILURE 3 0.0000
79 DIPLOPIA 1 0.0000
80 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
81 HAEMOPTYSIS 1 0.0000
82 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
83 BLOOD POTASSIUM DECREASED 1 0.0000
84 ILL-DEFINED DISORDER 2 0.0000
85 DELIRIUM 1 0.0000
86 THERAPY INTERRUPTED 2 0.0000
87 C-REACTIVE PROTEIN INCREASED 1 0.0000
88 THROMBOCYTOPENIA 3 0.0000
89 HEPATIC FUNCTION ABNORMAL 1 0.0000
90 SEIZURE 3 0.0000
91 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
92 CARDIAC FAILURE 2 0.0000
93 TREATMENT FAILURE 2 0.0000
94 HYPOACUSIS 1 0.0000
95 OVERDOSE 5 0.0000
96 TINNITUS 1 0.0000
97 COMA 1 0.0000
98 PRODUCTIVE COUGH 1 0.0000
99 OFF LABEL USE 18 0.0000
100 CELLULITIS 1 0.0000
101 NERVOUSNESS 1 0.0000
102 SEPSIS 2 0.0000
103 OXYGEN SATURATION DECREASED 1 0.0000
104 SURGERY 1 0.0000
105 DEATH 14 0.0000
106 INCORRECT DOSE ADMINISTERED 3 0.0000
107 TREMOR 2 0.0000
108 GASTROINTESTINAL DISORDER 1 0.0000
109 ADVERSE DRUG REACTION 1 0.0000
110 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
111 NO ADVERSE EVENT 2 0.0000
112 ADVERSE EVENT 1 0.0000
113 CARDIAC DISORDER 1 0.0000
114 PULMONARY EMBOLISM 1 0.0000
115 CONDITION AGGRAVATED 3 0.0000
116 ILLNESS 1 0.0000
117 MUSCULAR WEAKNESS 1 0.0000
118 VISION BLURRED 1 0.0000
119 COUGH 2 0.0000
120 INFECTION 1 0.0000
121 PRODUCT DOSE OMISSION ISSUE 2 0.0000
122 PERIPHERAL SWELLING 1 0.0000
123 URINARY TRACT INFECTION 1 0.0000
124 MUSCLE SPASMS 1 0.0000
125 NASOPHARYNGITIS 1 0.0000
126 HYPERSENSITIVITY 1 0.0000
127 PRODUCT USE ISSUE 1 0.0000
128 HYPERTENSION 1 0.0000
129 DRUG INEFFECTIVE 6 0.0000
130 DECREASED APPETITE 1 0.0000
131 BACK PAIN 1 0.0000
132 PNEUMONIA 1 0.0000
133 PYREXIA 1 0.0000
134 FATIGUE 2 0.0000
135 NAUSEA 2 0.0000
136 ARTHRALGIA 1 0.0000
137 VOMITING 1 0.0000
138 DIZZINESS 1 0.0000
139 DYSPNOEA 1 0.0000
140 HEADACHE 1 0.0000